Following the publication of this scientific opinion, the Commission requested from the applicant some clarifications about the requested uses and maximum use levels of bixin and norbixin. Based on this, on 16 February 2017, the applicant submitted to the Commission modifications to the original application, such as a removal of some of the requested new uses and a modification of some of the requested use levels. On 2 March 2017, the Commission requested the Authority for technical assistance as regards the estimation of the exposure to bixin and norbixin on the basis of the revised uses and use levels proposed by the applicant.
Recital 12, Regulation (EU) 2020/771
In forcesince 11 Jun 2020